These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 3875430)
1. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect. Ravizzola G; Bonfanti C; Savoldi E; Turano A Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430 [TBL] [Abstract][Full Text] [Related]
2. Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases. Esposito S; Galante D; Barba D; Pennucci C; Limauro D Microbiologica; 1985 Apr; 8(2):197-204. PubMed ID: 3874342 [TBL] [Abstract][Full Text] [Related]
3. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ceftazidime and ceftriaxone. Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula. Esposito S; Galante D; Barba D Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963 [TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria. Abd-Elalim Eltahawy AT; Khalaf RM Chemioterapia; 1988 Apr; 7(2):75-8. PubMed ID: 3293818 [TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of ceftizoxime against gram-negative strains. Debbia E; Soro O Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115 [TBL] [Abstract][Full Text] [Related]
8. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Jones RN; Sader HS; Fritsche TR; Pottumarthy S Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923 [TBL] [Abstract][Full Text] [Related]
9. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases. Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123 [TBL] [Abstract][Full Text] [Related]
10. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases. Raimondi A; Mattina R; Cocuzza CE Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon]. Baumgärtner M; Grehn M; Wundt W Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin. Brenciaglia MI; Cipriani P; Ghezzi MC; Giordano A; Mancini C; Rivanera D; Filadoro F Chemioterapia; 1984 Aug; 3(4):246-9. PubMed ID: 6099754 [TBL] [Abstract][Full Text] [Related]
13. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents. Bell JM; Turnidge JD; Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610 [TBL] [Abstract][Full Text] [Related]
14. In vitro microbiological properties of mezlocillin compared with four cephalosporins. Esposito S; Galante D; Barba D Chemioterapia; 1986 Aug; 5(4):273-7. PubMed ID: 3490314 [TBL] [Abstract][Full Text] [Related]
15. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime]. Rouhan D; Le Noc P; Le Noc D Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713 [TBL] [Abstract][Full Text] [Related]
16. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens. Vouillamoz J; Moreillon P; Giddey M; Entenza JM J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780 [TBL] [Abstract][Full Text] [Related]
17. Compared sensitivities of 532 bacterial strains to six cephalosporins. Courtieu AL; Drugeon H Int J Clin Pharmacol Res; 1983; 3(3):195-201. PubMed ID: 6679522 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of ceftriaxone against clinical bacterial isolates in Nigeria. Obaseiki-Ebor EE; Afonya TC; Oyaide SM Chemotherapy; 1985; 31(2):130-7. PubMed ID: 3872779 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species. Farrell DJ; Robbins M; Rhys-Williams W; Love WG Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634 [TBL] [Abstract][Full Text] [Related]
20. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains]. Mascellino MT; Prignano G; Iegri F; Lorenzi A Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]